References
- Balakumar P, Singh H, Singh M, et al. The impairment of preconditioning-mediated cardioprotection in pathological conditions. Pharmacol Res. 2009;60:18–23
- Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest. 2005;115:500–508.
- Hsieh DJ, Huang CY, Pai P, et al. Prolactin protects cardiomyocytes against intermittent hypoxia-induced cell damage by the modulation of signaling pathways related to cardiac hypertrophy and proliferation. Int J Cardiol. 2015;181:255–266.
- Tibaut M, Mekis D, Petrovic D. Pathophysiology of myocardial infarction and acute management strategies. Cardiovasc Hematol Agents Med Chem. 2017;14:150–159.
- Chugh SS, Aro AL. Coronary ischemia: global trigger of sudden cardiac death. Heart Rhythm. 2017;14:88–89.
- Semenza GL. Hypoxia-inducible factor 1 and cardiovascular disease. Annu Rev Physiol. 2014;76:39–56.
- Joshi S, Singh AR, Durden DL. MDM2 regulates hypoxic hypoxia-inducible factor 1alpha stability in an E3 ligase, proteasome, and PTEN-phosphatidylinositol 3-kinase-AKT-dependent manner. J Biol Chem. 2014;289(33):22785–22797.
- Blanco Pampin J, Garcia Rivero SA, Otero Cepeda XL, et al. Immunohistochemical expression of HIF-1alpha in response to early myocardial ischemia. J Forensic Sci. 2006;51:120–124.
- Vasagiri N, Kutala VK. Structure, function, and epigenetic regulation of BNIP3: a pathophysiological relevance. Mol Biol Rep. 2014;41:7705–7714.
- Jianqiang P, Ping Z, Xinmin F, et al. Expression of hypoxia-inducible factor 1 alpha ameliorate myocardial ischemia in rat. Biochem Biophys Res Commun. 2015;465:691–695.
- Zhang S, Wang J, Pan J. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats. Drug Deliv. 2016;23:3696–3703.
- Zhang J, Liu S, Xu B, et al. Study of baicalin on sympathoexcitation induced by myocardial ischemia via P2X3 receptor in superior cervical ganglia. Auton Neurosci. 2015;189:8–15.
- Xue Y, Shui X, Su W, et al. Baicalin inhibits inflammation and attenuates myocardial ischaemic injury by aryl hydrocarbon receptor. J Pharm Pharmacol.. 2015;67:1756–1764.
- Liu X, Gu J, Fan Y, et al. Baicalin attenuates acute myocardial infarction of rats via mediating the mitogen-activated protein kinase pathway. Biol Pharm Bull. 2013;36:988–994.
- Long TY, Jing R, Kuang F, et al. CIRBP protects H9C2 cells against myocardial ischemia through inhibition of NF-kappaB pathway. Braz J Med Biol Res. 2017;50(4):e5861.
- Bijlsma MF, Groot AP, Oduro JP, et al. Hypoxia induces a hedgehog response mediated by HIF-1alpha. J Cell Mol Med. 2009;13:2053–2060.
- Chu Y, Fang Y, Chi J, et al. Astragalus polysaccharides decrease proliferation, migration, and invasion but increase apoptosis of human osteosarcoma cells by up-regulation of microRNA-133a. Braz J Med Biol Res. 2018;51:e7665.
- Zhao R, Feng J, He G. Hypoxia increases Nrf2-induced HO-1 expression via the PI3K/Akt pathway. Front Biosci (Landmark Ed). 2016;21:385–396.
- Lin L, Knowlton AA. Innate immunity and cardiomyocytes in ischemic heart disease. Life Sci. 2014;100:1–8.
- Olivas-Chacon CI, Mullins C, Solberg A, et al. Assessment of ischemic cardiomyopathy using cardiovascular magnetic resonance imaging: a pictorial review. J Clin Imaging Sci. 2015;5:37.
- Shan M, Yu S, Yan H, et al. A review on the phytochemistry, pharmacology, pharmacokinetics and toxicology of geniposide, a natural product. Molecules. 2017;22:1689.
- Licciardi PV, Underwood JR. Plant-derived medicines: a novel class of immunological adjuvants. Int Immunopharmacol. 2011;11:390–398.
- Jiang WB, Zhao W, Chen H, et al. Baicalin protects H9c2 cardiomyocytes against hypoxia/reoxygenation-induced apoptosis and oxidative stress through activation of mitochondrial aldehyde dehydrogenase 2. Clin Exp Pharmacol Physiol. 2018;45:303–311.
- Salceda S, Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem. 1997;272:22642–22647.
- Li HL, Gu XH, Li BJ, et al. Characterization and functional analysis of hypoxia-inducible factor HIF1alpha and its inhibitor HIF1alphan in tilapia. PLOS One. 2017;12:e0173478.
- Song L, Yang H, Wang HX, et al. Inhibition of 12/15 lipoxygenase by baicalein reduces myocardial ischemia/reperfusion injury via modulation of multiple signaling pathways. Apoptosis. 2014;19:567–580.
- Shao ZH, Vanden Hoek TL, Qin Y, et al. Baicalein attenuates oxidant stress in cardiomyocytes. Am J Physiol Heart Circ Physiol. 2002;282:H999–H1006.
- Gallorini M, Petzel C, Bolay C, et al. Activation of the Nrf2-regulated antioxidant cell response inhibits HEMA-induced oxidative stress and supports cell viability. Biomaterials. 2015;56:114–128.
- Tong F, Zhou X. The Nrf2/HO-1 pathway mediates the antagonist effect of L-arginine on renal ischemia/reperfusion injury in rats. Kidney Blood Press Res. 2017;42:519–529.
- Zeng X, Li J, Li Z. Ginsenoside Rd mitigates myocardial ischemia-reperfusion injury via Nrf2/HO-1 signaling pathway. Int J Clin Exp Med. 2015;8:14497–14504.
- Wang Y, Che J, Zhao H, et al. Platycodin D inhibits oxidative stress and apoptosis in H9c2 cardiomyocytes following hypoxia/reoxygenation injury. Biochem Biophys Res Commun. 2018;503:3219–3224.
- Cheng FC, Geng L, Li L, et al. Baicalin attenuates intestinal ischemia/reperfusion injury and alters intestinal expression of Nrf2 and HO-1 in rats. WCJD. 2014;22:1510.